AAN’s Migraine Prevention Guideline is Now Open for Public Comment

The American Academy of Neurology (AAN) has announced that their latest guideline, “Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Update: Report of the AAN Guidelines Subcommittee,” is now open for public comment. This practice guideline offers updated evidence-based conclusions and recommendations on the use of pharmacologic migraine prevention in adults.

The primary objective of this practice guideline is to thoroughly assess all high-quality randomized controlled trials that investigate the efficacy of pharmacologic preventive treatments for both episodic and chronic migraine. The aim is to provide healthcare providers with clear recommendations on the use of pharmacologic preventive treatments.

As part of AAN’s development process, they invite reviews and feedback from neurologists, other healthcare professionals, researchers, people with migraine, and caregivers of people with migraine. Interested parties are encouraged to submit their comments here by September 8, 2024. Your input is valuable in shaping the future of migraine prevention.